Blood pressure lowering n-pyridyl-, n-quinolyl-, and n-piperdyl-n-acyl amino acid derivatives and method
US4588734A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Nov 19, 1984 |
| Grant date | May 13, 1986 |
| Priority date | — |
| Expiry date | Nov 19, 2004 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/48
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds of the structure: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, and R.sub.6 are hydrogen, alkyl, alkenyl, alkynyl, phenyl-alkyl, or cycloalkyl, PA1 n is an integer from 0 to 4 inclusive, PA1 M is heterocyclic or heterocyclic alkyl, PA1 Y is hydroxy, alkoxy, amino, or substituted amino, amino-alkanoyl, aryloxy, aminoalkoxy, or hydroxyalkoxy, and PA1 R.sub.7 is hydrogen, alkanoyl, carboxylalkanoyl, hydroxyalkanoyl, amino-alkanoyl, cyano, amidino, carbalkoxy, ZS, or ##STR2## wherein Z is hydrogen, alkyl, hydroxyalkyl, aminoalkyl or the radical ##STR3## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, n, M and Y are as described above; and where Y is hydroxy their nontoxic, pharmaceutically acceptable alkali metal, alkaline earth metal, and amine salts. These compounds possess antihypertensive and angiotensin converting enzyme inhibitory activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.